Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Alector Inc.

1.49
+0.03002.05%
Post-market: 1.530.0400+2.68%19:30 EST
Volume:1.47M
Turnover:2.19M
Market Cap:162.64M
PE:-1.39
High:1.54
Open:1.46
Low:1.41
Close:1.46
52wk High:3.40
52wk Low:0.8700
Shares:109.15M
Float Shares:92.51M
Volume Ratio:0.65
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0754
EPS(LYR):-1.2325
ROE:-121.98%
ROA:-17.84%
PB:2.82
PE(LYR):-1.21

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
Alector Inc.
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
156
Office Location:
131 Oyster Point Boulevard,Suite 600,South San Francisco,California,United States
Website:
http://www.alector.com
Zip Code:
94080
Phone:
415 231 5660
Fax:
- -
Introduction:
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its pipeline products include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001, AL002, and AL101 to treat neurodegenerative diseases. Alector, Inc. was founded in 2013 and is headquartered in South San Francisco, California.

Directors

Name
Position
Arnon Rosenthal
Co-founder, Chief Executive Officer and Director
Louis J. Lavigne, Jr.
Chairperson and Director
David Wehner
Director
Elizabeth Garofalo
Director
Errol De Souza
Director
Kristine Yaffe
Director
Mark Altmeyer
Director
Paula Hammond
Director
Richard Scheller
Director

Shareholders

Name
Position
Arnon Rosenthal
Co-founder, Chief Executive Officer and Director
Neil Berkley
Chief Business Officer and Interim Chief Financial Officer
Gary Romano
Chief Medical Officer
Grace Wong Sarad
Vice President Accounting and Principal Accounting Officer